# Cooper Companies Faces Strategic Shift After Earnings Plunge

> Cooper Companies stock drops 26% after management cuts 2026 guidance and retains CooperSurgical unit.
- Title: Cooper Companies Faces Strategic Shift After Earnings Plunge
- Summary: Cooper Companies stock drops 26% after management cuts 2026 guidance and retains CooperSurgical unit. Cooper Companies stock fell 26% following a…
- Keywords: cooper companies, coopersurgical, coopervision, jana partners, nasdaq:coo, free cash flow, share buyback, earnings guidance, strategic review, contact lenses, myday lenses, mindsight toric lenses
- Source: TradingView — https://tradingview.com/chart/COO/QWF5bEiM-Cooper-Companies-Hurst-s-cycles-suggests-adding-it-2-watch-list
- Published: 2026-10-19T09:46:12+00:00
- Read time: 2 min
- Topics: cooper companies, coopersurgical, coopervision, jana partners, nasdaq:coo, free cash flow, share buyback, earnings guidance, strategic review, contact lenses, myday lenses, mindsight toric lenses
## Cooper Companies Earnings Plunge
Cooper Companies stock dropped 26% after management cut full-year 2026 revenue guidance and decided to retain CooperSurgical instead of selling it.

> Cooper Companies. Hurst's cycles suggests adding it 2 watch list for NASDAQ:COO
## Hurst Cycles Technical Analysis
Hurst cycles suggest Cooper Companies stock may be near a price trough with potential for a sharp rebound.

> Hurst Cycles are a technical analysis framework developed in the 1970s by aerospace engineer and market researcher J.M. Hurst
## Bullish Case for Cooper
Cooper Companies anticipates $2 billion in free cash flow over three years to fund a $3 billion share buyback program.

> The Bullish Case • Inflection in Free Cash Flow: A multi-year capital expenditure cycle, primarily driven by expanding internal capacity for premium MyDAY contact lenses, is finally winding down
## Bearish Case for Cooper
Cooper Companies faces slowing core momentum with revenue missing expectations and guidance cuts.

> The Bearish Case • Slowing Core Momentum & Guidance Cuts: Third-quarter revenue of $1.066 billion missed expectations
## CooperSurgical Valuation Overhang
CooperSurgical faces structural pressures including soft capital equipment sales and flat performance from non-hormonal IUDs.

> The CooperSurgical Valuation Overhang: Deciding to retain CooperSurgical dismantled a massive catalyst for an immediate unlock of shareholder value
## Jana Partners Campaign
Jana Partners holds 1.8% stake and has threatened a proxy fight to replace CEO and force asset sales.

> JANA Partners is deeply embedded in COO, holding an approximate 1.8% stake (3.58 million shares)
## Director Stock Purchases
Three directors bought $1.8 million worth of Cooper Companies stock immediately after earnings guidance cut.

> Lawrence Erik Kurzius (Director): September 16, 2026: Purchased 10,000 shares at $54.93 per share (Value: $549,320)
## Market Reaction
Institutional investors show mixed signals with 416 funds adding positions versus 268 funds removing positions.

> Over the most recent rolling tracking cycle, 416 active mutual funds and institutional managers function as buyers
## CooperSurgical Strategic Shift
CooperSurgical faces market share erosion and declining capital equipment sales due to competitive pressures.

> Fresh competitive entrants into the non-hormonal long-acting reversible contraceptive (LARC) market are breaking Paragard's monopoly
## Elliott Wave Analysis
Elliott wave analysis shows potential for a price reversal but requires confirmation of wave completion.

> In Elliott wave counts we do not confirm until it's well established and finished = This count is not valid until it's proven after the fact
## Cooper Companies Fundamentals
Cooper Companies stock trades at 12.6x forward earnings with activist support for leadership refresh.

> At roughly 12.6x forward earnings, the stock sits well below its historical premium multiples
## Strategic Implications
Cooper Companies' long-term financial modeling shifts from steady growth to margin recovery and share repurchases.

> These factors will directly alter its long-term financial modeling for the 2027, 2030 time horizon
## Market Sentiment
Cooper Companies stock has fallen 29% since closing at $76.73 on August 19, 2026.

> Barron's chose Cooper Cos. a stock pick on Aug. 7. Shares have declined 26% since then as of the closing bell on Thursday
## CooperSurgical Market Position
CooperSurgical faces declining market share and structural pressures from competitive entrants.

> The primary headwind facing the CooperVision division is severe channel inventory destocking in the U.S.
## Next Steps
Cooper Companies faces potential leadership changes and strategic realignment following activist pressure.

> JANA has explicitly threatened a full-scale proxy fight ahead of the upcoming January nomination deadline if management refuses to cooperate
## Key takeaway

Cooper Companies stock fell 26% following a post-earnings plunge after management cut full-year 2026 revenue guidance and decided to keep CooperSurgical instead of selling it.